North America Diabetes Devices Market Size & Outlook
Related Markets
North America diabetes devices market highlights
- The North America diabetes devices market generated a revenue of USD 20,270.8 million in 2025.
- The market is expected to grow at a CAGR of 11.1% from 2026 to 2033.
- In terms of segment, blood glucose monitoring (bgm) devices was the largest revenue generating type in 2025.
- Blood Glucose Monitoring (BGM) Devices is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 20,270.8 million |
| Market revenue in 2033 | USD 47,098.9 million |
| Growth rate | 11.1% (CAGR from 2026 to 2033) |
| Largest segment | Blood glucose monitoring (bgm) devices |
| Fastest growing segment | Blood Glucose Monitoring (BGM) Devices |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Delivery Devices, Blood Glucose Monitoring (BGM) Devices |
| Key market players worldwide | Medtronic PLC, Abbott Laboratories, Roche Holding AG, Bayer AG, Johnson & Johnson, B. Braun, DexCom Inc, Insulet Corp, Ypsomed Holding AG, Sanofi SA, Novo Nordisk A/S ADR, Arkray |
Other key industry trends
- In terms of revenue, North America region accounted for 44.2% of the global diabetes devices market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- North America is the fastest growing regional market and is projected to reach USD 47,098.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Devices Market Scope
Diabetes Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| DexCom Inc | View profile | 9600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | https://www.dexcom.com |
| Arkray | View profile | 5001-10000 | Kyoto-shi, Kyoto, Japan, Asia | https://www.arkray.co.jp/japanese/index.html |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | https://www.bbraun.co.uk |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Insulet Corp | View profile | 3000 | 100 Nagog Park, Acton, MA, United States, 01720 | https://www.insulet.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
North America diabetes devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes devices market will help companies and investors design strategic landscapes.
Blood glucose monitoring (bgm) devices was the largest segment with a revenue share of 71.84% in 2025. Horizon Databook has segmented the North America diabetes devices market based on insulin delivery devices, blood glucose monitoring (bgm) devices covering the revenue growth of each sub-segment from 2021 to 2033.
North America dominated the diabetes devices market in 2022 with the largest market share and is expected to maintain its dominance during the forecast period. Major factors contributing to the growth of this region include increasing geriatric population, growing burden of diabetes due to lifestyle changes, increasing prevalence of obesity, and high cost of treatment.
Some of the market leaders, such as Abbott, Medtronic, Dexcom, and Insulet Corporation, have their operational headquarters in this region, which is contributing to the market growth. According to American Diabetes Association, in 2021, the North America and Caribbean Region had the highest expenditure for diabetes of around USD 415 billion, which accounted for around 43% of global expenditure.
Furthermore, the adoption of smart diabetes devices and technologically advanced devices such as the use of Artificial Intelligence (AI) & data analytics are driving the market. According to the International Diabetes Federation, one in eight adults suffers from impaired blood glucose tolerance. This ratio is expected to increase further during the forecast period.
Reasons to subscribe to North America diabetes devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America diabetes devices market databook
-
Our clientele includes a mix of diabetes devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America diabetes devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America diabetes devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America diabetes devices market size, by country, 2021-2033 (US$M)
North America Diabetes Devices Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
